Literature DB >> 3655143

Silent ischemia predicts infarction and death during 2 year follow-up of unstable angina.

S O Gottlieb1, M L Weisfeldt, P Ouyang, E D Mellits, G Gerstenblith.   

Abstract

Silent myocardial ischemia as detected on Holter electrocardiographic (ECG) monitoring is present in greater than 50% of patients with unstable angina despite intensive medical therapy. The presence and the extent of silent ischemia have been correlated with an increased risk of early (1 month) unfavorable outcome including myocardial infarction and need for coronary revascularization for persistent symptoms. Seventy patients with unstable angina who had undergone continuous ECG monitoring for silent ischemia were followed up for 2 years; 37 patients (Group I) had Holter ECG evidence of silent ischemia at bed rest in the coronary care unit during medical treatment with nitrates, beta-receptor blockers and calcium channel antagonists; the other 33 patients (Group II) had no ischemic ST segment changes (symptomatic or silent) on Holter monitoring. Over a 2 year follow-up period, myocardial infarction occurred in 10 patients in Group I (in 2 it was fatal) compared with one nonfatal infarction in Group II (p less than 0.01 by Kaplan-Meier analysis); revascularization with either coronary bypass surgery or angioplasty for symptomatic ischemia was performed in 11 Group I and 5 Group II patients (p less than 0.05). Multivariate Cox's hazard analysis demonstrated that the presence of silent ischemia was the best predictor of 2 year outcome. Therefore, persistent silent myocardial ischemia despite medical therapy in patients with unstable angina carries adverse prognostic implications that persist over a 2 year period.

Entities:  

Mesh:

Year:  1987        PMID: 3655143     DOI: 10.1016/s0735-1097(87)80267-x

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  23 in total

1.  Cumulative risk assessment in unstable angina: clinical, electrocardiographic, autonomic, and biochemical markers.

Authors:  S Kennon; C P Price; P G Mills; P K MacCallum; J Cooper; J Hooper; H Clarke; A D Timmis
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

Review 2.  Silent myocardial ischaemia. Implications for therapy.

Authors:  N G Uren; D P Lipkin
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

Review 3.  Diagnostic and prognostic value of ambulatory ECG (Holter) monitoring in patients with coronary heart disease: a review.

Authors:  C Michael Gibson; Lauren N Ciaglo; Matthew C Southard; Shaun Takao; Caitlin Harrigan; Jason Lewis; Jason Filopei; Michelle Lew; Sabina A Murphy; Jacqueline Buros
Journal:  J Thromb Thrombolysis       Date:  2007-04       Impact factor: 2.300

Review 4.  Management strategies for a better outcome in unstable coronary artery disease.

Authors:  R W Campbell; L Wallentin; F W Verheugt; A G Turpie; A Maseri; W Klein; J G Cleland; C Bode; R Becker; J Anderson; M E Bertrand; C R Conti
Journal:  Clin Cardiol       Date:  1998-05       Impact factor: 2.882

Review 5.  Silent myocardial ischaemia.

Authors:  S Campbell
Journal:  BMJ       Date:  1988-09-24

Review 6.  [Significance of silent myocardial ischemia for identification and optimal therapy of patients with latent coronary heart disease. Is there a marker for prognostic indication for PTCA?].

Authors:  D Hering; H P Schultheiss; D Horstkotte
Journal:  Herz       Date:  1999-02       Impact factor: 1.443

7.  2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry.

Authors:  Jonathan S Steinberg; Niraj Varma; Iwona Cygankiewicz; Peter Aziz; Paweł Balsam; Adrian Baranchuk; Daniel J Cantillon; Polychronis Dilaveris; Sergio J Dubner; Nabil El-Sherif; Jaroslaw Krol; Malgorzata Kurpesa; Maria Teresa La Rovere; Suave S Lobodzinski; Emanuela T Locati; Suneet Mittal; Brian Olshansky; Ewa Piotrowicz; Leslie Saxon; Peter H Stone; Larisa Tereshchenko; Mintu P Turakhia; Gioia Turitto; Neil J Wimmer; Richard L Verrier; Wojciech Zareba; Ryszard Piotrowicz
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-05       Impact factor: 1.468

Review 8.  The clinical significance of continuous ECG (ambulatory ECG or Holter) monitoring of the ST-segment to evaluate ischemia: a review.

Authors:  Neil J Wimmer; Benjamin M Scirica; Peter H Stone
Journal:  Prog Cardiovasc Dis       Date:  2013-08-16       Impact factor: 8.194

9.  Postoperative myocardial infarction and cardiac death. Predictive value of dipyridamole-thallium imaging and five clinical scoring systems based on multifactorial analysis.

Authors:  J Lette; D Waters; J Lassonde; S Dubé; F Heyen; M Picard; M Morin
Journal:  Ann Surg       Date:  1990-01       Impact factor: 12.969

10.  Assessment of Holter ST monitoring for risk stratification in patients with acute myocardial infarction treated by thrombolysis.

Authors:  R Stevenson; K Ranjadayalan; P Wilkinson; B Marchant; A D Timmis
Journal:  Br Heart J       Date:  1993-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.